Related Experiment Video
Updated: Jul 1, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
A Framework of Institutional Obligations for Pragmatic Clinical Trials
Stephanie R Morain1, Matthew W Semler2, Jonathan D Casey2
1Johns Hopkins University.
None:
Pragmatic clinical trials (PCTs) embed research into clinical care. This deliberate research-care integration means that healthcare institutions are key partners for PCTs. Prior literature has identified several ethical challenges in PCTs for which institutional involvement is a necessary condition for their resolution. However, no comprehensive account exists to describe the moral obligations of healthcare institutions for PCTs. To that end, we propose a framework of ten obligations for institutions when leading or participating in PCTs. These obligations span the lifecycle of research, beginning with decisions about whether to implement a given study within a particular institution through to decisions about (de)implementation following study completion. For each obligation, we describe both the relevant moral considerations and the corresponding practical implications. While we offer several practical suggestions that can inform current research activities, future work will be needed to further specify these obligations to provide more granular guidance for decision-making.
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Preclinical Development: Overview
Ethics in Research
Clinically Relevant Drug Product Specifications: Methods of Establishment
Ethical Standards I
The Code of Ethics provisions outline the nurse's duty to the patient, the healthcare team, the profession, and society. The Code's fundamental principles include advocacy,...

